FDA Approved: HETLIOZ — Supplemental Application (Vanda Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for HETLIOZ (tasimelteon) by Vanda Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-24-hour Sleep-wake Disorder

Drugs mentioned

• Hetlioz (tasimelteon)

Snippet

SUPPL AP for HETLIOZ (TASIMELTEON)